Maria Palasis - 15 Jun 2023 Form 4/A - Amendment Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
President & CEO, Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Maria Palasis, Ph.D.
Issuer symbol
LYRA
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
12 Jul 2023, 18:36:36 UTC
Date Of Original Report
26 Jun 2023
Previous filing
02 Feb 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +150,000 $0.000000 150,000 15 Jun 2023 Common Stock 150,000 $2.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 15, 2023.
F2 This Form 4 amendment is being filed to correct the expiration date of the stock option granted to the Reporting Person.